Sign Path Pharma Inc is categorized under Medical Research in Quakertown, PA and active since 2006.
Sign Path Pharma Inc was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Lawrence Helson, Chief Executive Officer at the company’s headquarters by writing to 1375 California Road, Quakertown, Pennsylvania PA 18951 or by phoning (215) 538-9996. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sign Path Pharma Inc |
| Contact Person: | Lawrence Helson, Chief Executive Officer |
| Address: | 1375 California Road, Quakertown, Pennsylvania 18951 |
| Phone Number: | (215) 538-9996 |
| Website Address: | signpathpharma.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417114 |
| Share This Business: |
Sign Path Pharma Inc was started in 2006 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Lawrence Helson, Chief Executive Officer for inquiries that concern Sign Path Pharma Inc by calling the company number (215) 538-9996, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Sign Path Pharma Inc can be found at the coordinates 40.480037,-75.339537 as well as the street address 1375 California Road in Quakertown, Pennsylvania 18951.
For its online presence, you may visit Sign Path Pharma Inc’s website at signpathpharma.com and engage with its social media outlets through on Twitter and on Facebook.